Management of Acute and Chronic Severe Heart Failure
As the population ages, the medical profession predicts that the prevalence of heart failure will continue to increase at least through 2030. Advances in medical and surgical therapy are allowing more people to survive acute cardiac events and to live longer with heart failure; however, morbidity and mortality remain high. MCS has become mainstay therapy for severe acute and chronic heart failure....
As the population ages, the medical profession predicts that the prevalence of heart failure will continue to increase at least through 2030. Advances in medical and surgical therapy are allowing more people to survive acute cardiac events and to live longer with heart failure; however, morbidity and mortality remain high. MCS has become mainstay therapy for severe acute and chronic heart failure....